{"entity":{"id":"nct04443088","kind":"trial","name":"An Open-Label Study of INV-1120 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors","aka":[],"tldr":"A phase 1 trial of INV-1120 run by Shenzhen Ionova Life Sciences Co., Ltd., now recruiting.","summary":"An Open-Label Study of INV-1120 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors is a phase 1 interventional study registered as NCT04443088 by Shenzhen Ionova Life Sciences Co., Ltd., with 78 participants planned, started 2020-06-26. Conditions recorded: Cancer, Solid Tumor, Adult, Cancer Metastatic, Solid Carcinoma, Solid Tumor, Unspecified, Adult and Tumor, Solid. Interventions recorded: INV-1120 and Pembrolizumab.","status":"recruiting","asOf":"2026-11-03","links":[{"label":"ClinicalTrials.gov NCT04443088","url":"https://clinicaltrials.gov/study/NCT04443088"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["metastatic-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":["inv-1120"],"companies":["shenzhen-ionova-life-sciences"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT04443088","phase":"1","setting":"A Phase 1a/1b, Multi-Center, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Evidence of Antitumor Activity of INV-1120 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors","sponsor":"Shenzhen Ionova Life Sciences Co., Ltd.","enrolled":78,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct04443088/","neighbours":{"cancer":[{"id":"metastatic-cancer","kind":"cancer","name":"Metastatic cancer (cancer that has spread)","route":"/cancers/metastatic-cancer/"}],"drug":[{"id":"inv-1120","kind":"drug","name":"INV-1120","route":"/drugs/inv-1120/"}],"company":[{"id":"shenzhen-ionova-life-sciences","kind":"company","name":"Shenzhen Ionova Life Sciences","route":"/companies/shenzhen-ionova-life-sciences/"}]}}